摘要
断奶后多系统衰弱综合征(PMWS)是目前规模化猪场常见的传染病,由PCV2感染引起。临床上PCV2与PRRSV混合感染较常见,死亡率和发病率很高,但目前尚无能有效预防该病的商品化疫苗。本研究利用基因克隆方法,构建融合表达PCV2-Cap蛋白与PRRSV-GP5蛋白的重组腺病毒rAd-Cap-GP5,经IPMA、IFA和Western blotting验证了Cap蛋白和GP5蛋白在该重组病毒中获得表达。将该重组腺病毒免疫小鼠测定其抗体、中和抗体,结果显示小鼠免疫后出现两种病毒的抗体和中和抗体,诱导小鼠产生明显的体液免疫应答,可以作为预防PCV2-PRRSV混合感染的基因工程疫苗候选毒株,为PCV2和PRRSV二联重组亚单位疫苗的研究奠定了基础。
Porcine circovirus 2(PCV2) has been implicated as the etiological agent of postweaning multisystemic wasting syndrome(PMWS).Co-infection of PCV2 and porcine reproductive and respiratory syndrome virus(PRRSV) can result in severe economic losses to the swine industry.In this study,we constructed the recombinant adenovirus rAd-Cap-GP5 expressing Cap of PCV2 and GP5 of PRRSV.And the expression of Cap and GP5 protein in the HEK-293 cells inoculated with rAd-Cap-GP5 were confirmed by immunoperoxidase monolayer assay(IPMA),indirect immunofluorescence assay(IFA) and Western blotting,respectively.The immunogenicity of recombinant adenoviruses rAd-Cap-GP5 was examined in mice by vaccination with the recombinant adenovirus.The results showed that the mice could produce anti-PCV2 and PRRSV antibodies detected by indirect ELISA and virus neutralization assay.It indicated that rAd-Cap-GP5 could provide humoral immunity responses in mice.The recombinant adenovirus rAd-Cap-GP5 might be an attractive candidate vaccine for preventing the disease associated with PCV2 and PRRSV infection.
出处
《生物工程学报》
CAS
CSCD
北大核心
2009年第11期1639-1645,共7页
Chinese Journal of Biotechnology
基金
国家自然科学基金(No.30871868)
国家科技支撑计划(Nos.2007BAD86B02-3
2006BAD06A04)
江苏省科技攻关项目(No.BE2007342)
教育部博士点基金项目(No.20060307007)资助~~